Skip to main content
Home / The International Journal of Tuberculosis and Lung Disease, Volume 16, Number 10

The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

Publisher: International Union Against Tuberculosis and Lung Disease

More about this publication?
Volume 16, Number 10, 1 October 2012

editorial

On the road to unravelling the aetiology of non-tuberculous mycobacterial disease [Editorial]
pp. 1279-1279(1)
Authors: van Soolingen, Dick; van Ingen, Jakko

Favourites:
ADD

Restrictive lung disease: not restricted to the lung? [Editorial]
pp. 1280-1280(1)
Authors: Bhatt, Surya P.; Dransfield, Mark T.

Favourites:
ADD

review-article

New tuberculosis technologies: challenges for retooling and scale-up [State of the art series. New tools. Number 4 in the series]
pp. 1281-1290(10)
Authors: Pai, M.; Palamountain, K. M.

Favourites:
ADD

2011: The year in review. Part II: Tuberculosis and lung disease
pp. 1291-1299(9)
Authors: Iademarco, M. F.; Koh, W. J.

Favourites:
ADD

research-article

Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment
pp. 1300-1306(7)
Authors: Jung, Y. J.; Lyu, J.; Yoo, B.; Lee, C-K.; Kim, Y-G.; Yang, S-K.; Byeon, J-S.; Kim, K. J.; Ye, B. D.; Lee, K-H.; Lee, S-D.; Kim, W. S.; Kim, D. S.; Shim, T. S.

Favourites:
ADD

Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting
pp. 1307-1314(8)
Authors: Saidenberg-Kermanac'h, N.; Semerano, L.; Naccache, J. M.; Brauner, M.; Falgarone, G.; Dumont-Fischer, D.; Guillot, X.; Valeyre, D.; Boissier, M-C.

Favourites:
ADD

Trend in tuberculosis infection prevalence in a rural area in South India after implementation of the DOTS strategy
pp. 1315-1319(5)
Authors: Kolappan, C.; Subramani, R.; Chandrasekaran, V.; Thomas, A.

Favourites:
ADD

Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995–2010
pp. 1320-1325(6)
Authors: Denholm, J. T.; Leslie, D. E.; Jenkin, G. A.; Darby, J.; Johnson, P. D. R.; Graham, S. M.; Brown, G. V.; Sievers, A.; Globan, M.; Brown, L. K.; McBryde, E. S.

Favourites:
ADD

Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines
pp. 1326-1330(5)
Authors: Gler, M. T.; Guilatco, R. S.; Guray, C. V.; Tupasi, T. E.

Favourites:
ADD

Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough
pp. 1331-1334(4)
Authors: Althomsons, S. P.; Cegielski, J. P.

Favourites:
ADD

Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis
pp. 1335-1343(9)
Authors: Kurbatova, E. V.; Gammino, V. M.; Bayona, J.; Becerra, M. C.; Danilovitz, M.; Falzon, D.; Gelmanova, I.; Keshavjee, S.; Leimane, V.; Mitnick, C. D.; Quelapio, M. I.; Riekstina, V.; Taylor, A.; Viiklepp, P.; Zignol, M.; Cegielski, J. P.

Favourites:
ADD

Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion
pp. 1344-1348(5)
Authors: Lee, J.; Lee, B. J.; Yoon, H. I.; Lee, C-T.; Lee, J. H.

Favourites:
ADD

Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile
pp. 1349-1353(5)
Authors: Balcells, M. E.; García, P.; Chanqueo, L.; Bahamondes, L.; Lasso, M.; Gallardo, A. M.; Cifuentes, L.

Favourites:
ADD

Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy [Short communication]
pp. 1354-1357(4)
Authors: Lawn, S. D.; Kerkhoff, A. D.; Pahlana, P.; Vogt, M.; Wood, R.

Favourites:
ADD

Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses
pp. 1358-1364(7)
Authors: Takuva, S.; Westreich, D.; Menezes, C. N.; McNamara, L.; Sanne, I.; Page-Shipp, L.; Maskew, M.

Favourites:
ADD

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients
pp. 1365-1370(6)
Authors: Breton, G.; Bourgarit, A.; Pavy, S.; Bonnet, D.; Martinez, V.; Duval, X.; Longuet, P.; Abgrall, S.; Simon, A.; Leport, C.; ANRS-EP21 (Agence Nationale de Recherche sur le Sida) Paradox TB Study Group

Favourites:
ADD

Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda
pp. 1371-1376(6)
Authors: Nansera, D.; Bajunirwe, F.; Elyanu, P.; Asiimwe, C.; Amanyire, G.; Graziano, F. M.

Favourites:
ADD

Tuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical features
pp. 1377-1382(6)
Authors: Barbosa, C. de B.; Lazzarini, L. C. O.; Elias, A. R.; Leung, J. A. M.; Ribeiro, S. B.; da Silva, M. G.; Duarte, R. S.; Suffys, P.; Gomes, H. M.; Kritski, A. L.; Lapa e Silva, J. R.; Ho, J. L.; Boéchat, N.

Favourites:
ADD

Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis
pp. 1383-1387(5)
Authors: Alavi-Naini, R.; Salimi, S.; Sharifi-Mood, B.; Davoodikia, A. A.; Moody, B.; Naghavi, A.

Favourites:
ADD

Mycobacterium bovis infection in livestock workers in Ibadan, Nigeria: evidence of occupational exposure
pp. 1388-1392(5)
Authors: Adesokan, H. K.; Jenkins, A. O.; van Soolingen, D.; Cadmus, S. I. B.

Favourites:
ADD

Clinical significance of mycobacterial genotyping in Mycobacterium avium lung disease in Korea
pp. 1393-1399(7)
Authors: Kim, S-Y.; Lee, S-T.; Jeong, B-H.; Jeon, K.; Kim, J-W.; Shin, S. J.; Koh, W-J.

Favourites:
ADD

Mycobacterium africanum, an emerging disease in high-income countries?
pp. 1400-1404(5)
Authors: Isea-Peña, M. C.; Brezmes-Valdivieso, M. F.; González-Velasco, M. C.; Lezcano-Carrera, M. A.; López-Urrutia-Lorente, L.; Martín-Casabona, N.; Monforte-Cirac, M. L.; Palacios, J. J.; Penedo-Pallares, A.; Ramirez-Rosales, A.; Sánchez-Silos, R.; Tórtola-Fernández, T.; Viñuelas-Bayón, J.; Vitoria-Agreda, A.; Red de Laboratorios de Microbiología Servicio de Salud del Principado de Asturias (SESPA); Esteban, J.

Favourites:
ADD

Restricted spirometry in the Burden of Lung Disease Study
pp. 1405-1411(7)
Authors: Mannino, D. M.; McBurnie, M. A.; Tan, W.; Kocabas, A.; Anto, J.; Vollmer, W. M.; Buist, A. S.; on behalf of the BOLD Collaborative Research Group

Favourites:
ADD

Public opinion on smoke-free policies among Egyptians
pp. 1412-1417(6)
Authors: Radwan, G. N.; Emam, A. H.; Maher, K. M.; Mehrez, M.; El-Sayed, N.; El-Nahas, G. M.

Favourites:
ADD

letter

Declaration on palliative care for MDR/XDR-TB [Correspondence]
pp. 1418-1419(2)
Authors: Laniado-Laborín, Rafael; Kiy, Richard; Spanevello, A.; D'Ambrosio, L.; Centis, R.; Migliori, G. B.

Favourites:
ADD

reply

In reply to ‘Declaration on palliative care for MDR/XDR-TB’ [Correspondence]
pp. 1419-1420(2)
Authors: Connor, Stephen; Foley, Kathy; Harding, Richard; Jaramillo, Ernesto

Favourites:
ADD

letter

Evaluation of the Amplified MTD® Test in respiratory specimens of human immunodeficiency virus patients [Correspondence]
pp. 1420-1420(1)
Authors: Barreto, Leonardo Bruno Paz Ferreira; Lourenço, Maria Cristina da Silva; Rolla, Valéria Cavalcanti; Veloso, Valdiléia Gonçalves; Huf, Gisele

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content